Reference. A Primer in Precision Nephrology: Optimizing Outcomes in Kidney Health and Disease through Data-Driven Medicine
This year marks the 63rd anniversary of the International Society of Nephrology, which signaled nephrology’s emergence as a modern medical discipline. In this article, we briefly trace the course of nephrology’s history to show a clear arc in its evolution—of increasing resolution in nephrological data—an arc that is converging with computational capabilities to enable precision nephrology. In general, precision medicine refers to tailoring treatment to the individual characteristics of patients. For an operational definition, this tailoring takes the form of an optimization, in which treatments are selected to maximize a patient’s expected health with respect to all available data. Because modern health data are large and high resolution, this optimization process requires computational intervention, and it must be tuned to the contours of specific medical disciplines. An advantage of this operational definition for precision medicine is that it allows us to better understand what precision medicine means in the context of a specific medical discipline. The goal of this article was to demonstrate how to instantiate this definition of precision medicine for the field of nephrology. Correspondingly, the goal of precision nephrology was to answer two related questions: ( 1 ) How do we optimize kidney health with respect to all available data? and ( 2 ) How do we optimize general health with respect to kidney data?
Cite
Cites 102 works (0 here)
External (102)
- Defining AKD: the spectrum of AKI, AKD, and CKD (2022)
- Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice (2022)
- Ethical implications of epigenetics in the era of personalized medicine (2022)
- Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcomes in patients with type 2 diabetes and other risk factors for cardiovascular disease: a meta-analysis (2022)
- Application of the international IgA nephropathy prediction tool one or two years post-biopsy (2022)
- In medicine, how do we machine learn anything real? (2022)
- Navigating the pitfalls of applying machine learning in genomics (2022)
- Cardiovascular disease in chronic kidney disease (2021)
- Population kidney health. A new paradigm for chronic kidney disease management (2021)
- Convergence of precision medicine and public health into precision public health: toward a big data perspective (2021)
- Nomenclature in nephrology: preserving ‘renal’ and ‘nephro’ in the glossary of kidney health and disease (2021)
- APOL1 nephropathy: from genetics to clinical applications (2021)
- APOL1 risk variants in kidney transplantation: a modulation of immune cell function (2021)
- Role of mitochondrial therapy for ischemic-reperfusion injury and acute kidney injury (2021)
- Australia and New Zealand renal gene panel testing in routine clinical practice of 542 families (2021)
- Clinical impact of genomic testing in patients with suspected monogenic kidney disease (2021)
- Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis (2021)
- Optimizing diet to slow CKD progression (2021)
- Novel urinary glycan profiling by lectin array serves as the biomarkers for predicting renal prognosis in patients with IgA nephropathy (2021)
- Editorial: kidney and distant organ crosstalk in health and disease (2021)
- Diabetes management in chronic kidney disease: synopsis of the 2020 KDIGO clinical practice guideline (2021)
- Race, genetic ancestry, and estimating kidney function in CKD (2021)
- Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease (2021)
- Artificial Intelligence Assessment of Renal Scarring (AIRS Study) (2021)
- Use of physiological data from a wearable device to identify SARS-CoV-2 infection and symptoms and predict COVID-19 diagnosis: observational study (2021)
- Wearable fitness trackers to predict clinical deterioration in maintenance hemodialysis: a prospective cohort feasibility study (2021)
- How will artificial intelligence change medical training? (2021)
- Crosstalk between the nervous system and the kidney (2020)
- Patient and caregiver perspectives on terms used to describe kidney health (2020)
- Diagnoses of uncertain significance: kidney genetics in the 21st century (2020)
- The mutational constraint spectrum quantified from variation in 141,456 humans (2020)
- ClinVar: improvements to accessing data (2020)
- Clinical applications of genetic discoveries in kidney transplantation: a review (2020)
- Mitochondrial disease and the kidney with a special focus on CoQ10 deficiency (2020)
- APOL1 long-term kidney transplantation outcomes network (APOLLO): design and rationale (2020)
- Pilot study of return of genetic results to patients in adult nephrology (2020)
- Clinical genetic screening in adult patients with kidney disease (2020)
- From theory to reality: establishing a successful kidney genetics clinic in the outpatient setting (2020)
- Initial experience from a renal genetics clinic demonstrates a distinct role in patient management (2020)
- Implementation of a renal precision medicine program: clinician attitudes and acceptance (2020)
- Using the exposome to address gene–environment interactions in kidney disease (2020)
- Longitudinal evolution of markers of mineral metabolism in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) study (2020)
- Genetics may predict effectiveness of tolvaptan in autosomal dominant polycystic kidney disease (2020)
- An interpretable machine learning survival model for predicting long-term kidney outcomes in IgA nephropathy (2020)
- Genetic overlap and causal inferences between kidney function and cerebrovascular disease (2020)
- Race, science and (im)precision medicine (2020)
- Modelling kidney disease using ontology: insights from the Kidney Precision Medicine Project (2020)
- Transitive sequencing medical records for mining predictive and interpretable temporal representations (2020)
- Automated CT biomarkers for opportunistic prediction of future cardiovascular events and mortality in an asymptomatic screening population: a retrospective cohort study (2020)
- Geographic distribution of US cohorts used to train deep learning algorithms (2020)
- Building, scaling, and sustaining a learning health system for surgical quality improvement: a toolkit (2020)
- Diagnostic utility of exome sequencing for kidney disease (2019)
- Prediction and risk stratification of kidney outcomes in IgA nephropathy (2019)
- Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis (2019)
- Evaluating a new international risk-prediction tool in IgA nephropathy (2019)
- Dissecting racial bias in an algorithm used to manage the health of populations (2019)
- A clinically applicable approach to continuous prediction of future acute kidney injury (2019)
- Introducing artificial intelligence training in medical education (2019)
- Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis (2018)
- Worldwide frequencies of APOL1 renal risk variants (2018)
- Towards precision nephrology: the opportunities and challenges of genomic medicine (2018)
- Precision medicine for nutritional management in end-stage kidney disease and transition to dialysis (2018)
- Precision medicine and personalized management of lipoprotein and lipid disorders in chronic and end-stage kidney disease (2018)
- The Precision Medicine Initiative’s All of Us Research Program: an agenda for research on its ethical, legal, and social issues (2017)
- Detecting PKD1 variants in polycystic kidney disease patients by single-molecule long-read sequencing (2017)
- Lessons learned from a multidisciplinary renal genetics clinic (2017)
- Acute kidney injury risk assessment: differences and similarities between resource-limited and resource-rich countries (2017)
- Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group (2017)
- Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes (2017)
- Changing bone patterns with progression of chronic kidney disease (2016)
- APOL1 variants (2016)
- Apolipoprotein L1 and kidney disease in African Americans (2016)
- Mitochondrial dysfunction in inherited renal disease and acute kidney injury (2016)
- A multidisciplinary renal genetics clinic improves patient diagnosis (2016)
- Acute kidney injury in low-resource settings: barriers to diagnosis, awareness, and treatment and strategies to overcome these barriers (2016)
- Insights into rare diseases from social media surveys (2016)
- A global reference for human genetic variation (2015)
- An integrated map of structural variation in 2,504 human genomes (2015)
- The search for monogenic causes of kidney stones (2015)
- Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure (2015)
- Understanding acute kidney injury in low resource settings: a step forward (2015)
- Acute kidney injury and chronic kidney disease as interconnected syndromes (2014)
- Chronic kidney disease and the skeleton (2014)
- Evolution of the primate trypanolytic factor APOL1 (2014)
- New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes (2014)
- Social media methods for studying rare diseases (2014)
- Mutations in NGLY1 cause an inherited disorder of the endoplasmic reticulum–associated degradation pathway (2014)
- The shifting model in clinical diagnostics: how next-generation sequencing and families are altering the way rare diseases are discovered, studied, and treated (2014)
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention (2013)
- Historical milestones in renal pathology (2012)
- An integrated map of genetic variation from 1,092 human genomes (2012)
- Prevalence of kidney stones in the United States (2012)
- Tolvaptan in patients with autosomal dominant polycystic kidney disease (2012)
- A map of human genome variation from population-scale sequencing (2010)
- Association of trypanolytic ApoL1 variants with kidney disease in African Americans (2010)
- A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index (2009)
- The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification (2009)
- The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility (2009)
- MYH9 is associated with nondiabetic end-stage renal disease in African Americans (2008)
- International IgA nephropathy network clinico-pathological classification of IgA nephropathy (2007)
- Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization (2004)
- Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization (2004)